Literature DB >> 8186370

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization.

M N Woodroofe1, M L Cuzner.   

Abstract

The predominant pathological features in the central nervous system (CNS) in multiple sclerosis (MS) are perivascular inflammation and demyelination. The cells in the inflammatory cuff consist mainly of T lymphocytes and macrophages. Cytokines produced by inflammatory cells within the CNS have the potential to enhance local inflammation and promote phagocytosis of myelin by macrophages, resulting in demyelination. Resident brain cells, microglia and astrocytes, also produce cytokines after stimulation in vitro. We have applied the technique of non-radioactive in situ hybridization to examine which cells in the CNS are producing cytokines in MS. Using digoxigenin-labelled oligonucleotide probes we have detected expression of the cytokines IL-1 alpha, IL-2, IL-4, IL-6, IL-10, IFN-gamma, TGF beta 1 & 2 and TNF-alpha in frozen sections of CNS tissue from MS cases. The intensity and distribution of the staining for mRNA is cytokine specific, IL-6, IFN-gamma and TNF-alpha predominating in the perivascular inflammatory cuffs, the others being more weakly expressed. Expression of all cytokine mRNAs is stronger in perivascular cells rather than in parenchymal cells, suggesting that circulating inflammatory cells which have crossed the blood brain barrier are the major source of cytokines in MS tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8186370     DOI: 10.1016/s1043-4666(05)80008-0

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  45 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology.

Authors:  B Bonetti; C Stegagno; B Cannella; N Rizzuto; G Moretto; C S Raine
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Authors:  Bharath Wootla; Jens O Watzlawik; Nikolaos Stavropoulos; Nathan J Wittenberg; Harika Dasari; Murtada A Abdelrahim; John R Henley; Sang-Hyun Oh; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Opin Biol Ther       Date:  2016-03-10       Impact factor: 4.388

4.  alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation.

Authors:  N Rajora; G Boccoli; D Burns; S Sharma; A P Catania; J M Lipton
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

5.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

6.  Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors.

Authors:  Jing Wang; Darpan Saraswat; Anjali K Sinha; Jessie Polanco; Karen Dietz; Melanie A O'Bara; Suyog U Pol; Hani J Shayya; Fraser J Sim
Journal:  Cell Rep       Date:  2018-12-18       Impact factor: 9.423

7.  Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells.

Authors:  G Wolswijk
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

8.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

9.  Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Authors:  Y Zoukos; T N Thomaides; D Kidd; M L Cuzner; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.